Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ali J. Satvat currently holds 26,014 shares of Eidos Therapeutics, Inc. (EIDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ali J. Satvat has been a net buyer of EIDX stock. They have purchased $116.2M and sold $0 worth of shares.
Ali J. Satvat's most recent insider trade was on Dec 30, 2024, when they sold 39,851 shares at $0.00 per share.
Ali J. Satvat serves as Executive at Eidos Therapeutics, Inc. (EIDX). They have executed 16 insider transactions totaling $116.2M over their tenure at the company.
Ali J. Satvat holds the position of Executive at Eidos Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Ali J. Satvat has shown a buying trading pattern, with $116.2M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Ali J. Satvat was on May 24, 2019, when they purchased $28.6M worth of EIDX shares. This transaction involved 1,103,848 shares at $25.93 per share.
Ali J. Satvat currently owns 26,014 shares of Eidos Therapeutics, Inc. (EIDX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ali J. Satvat's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ali J. Satvat has 16 Form 4 filings on record as an insider at Eidos Therapeutics, Inc..
Set alerts for Ali J. Satvat and 40,000+ other insiders.